Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Carteolol
Drug ID BADD_D00372
Description A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Indications and Usage For the treatment of intraocular hypertension and chronic open-angle glaucoma
Marketing Status approved
ATC Code C07AA15; S01ED05
DrugBank ID DB00521
KEGG ID D07624
MeSH ID D002354
PubChem ID 2583
TTD Drug ID D03GCJ
NDC Product Code Not Available
UNII 8NF31401XG
Synonyms Carteolol | OPC-1085 | OPC 1085 | OPC1085 | Carteolol Hydrochloride | Hydrochloride, Carteolol | Carteolol Monohydrochloride | Monohydrochloride, Carteolol
Chemical Information
Molecular Formula C16H24N2O3
CAS Registry Number 51781-06-7
SMILES CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Arrhythmia02.03.02.001--Not Available
Asthenia08.01.01.001--Not Available
Atrioventricular block02.03.01.002--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Cardiac failure congestive02.05.01.002--Not Available
Cerebral ischaemia24.04.06.003; 17.08.01.005--
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Conjunctivitis11.01.06.012; 06.04.01.002--
Depression19.15.01.001--
Diabetes mellitus14.06.01.001; 05.06.01.001--Not Available
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspnoea22.02.01.004; 02.11.05.003--
Eye irritation06.04.05.003--Not Available
Eyelid ptosis17.17.02.004; 06.05.01.002--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypoglycaemia14.06.03.001; 05.06.03.001--
Hypotension24.06.03.002--
Insomnia19.02.01.002; 17.15.03.002--
Keratitis06.04.02.002--
Lacrimation increased06.08.02.004--
Loss of consciousness17.02.04.004--Not Available
Nausea07.01.07.001--
Night blindness06.02.10.010; 14.12.03.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Palpitations02.11.04.012--
Photophobia17.17.02.006; 06.01.01.004--
The 1th Page    1 2    Next   Last    Total 2 Pages